Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Persistent Albuminuria: A Randomized Controlled Clinical Trial

NCT07405216 is registered in ClinicalTrials.gov with Centenario Hospital Miguel Hidalgo as lead sponsor.

NCT NCT07405216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Persistent Albuminuria: A Randomized Controlled Clinical Trial
Lead sponsor
Centenario Hospital Miguel Hidalgo
Phase
Phase 4
Overall status
Recruiting
Start date
April 23, 2026
Completion date
October 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent, albuminuria, chronic kidney disease (mild to moderate), sodium glucose co-transporter 2 inhibitors